HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A mutation in CaV2.1 linked to a severe neurodevelopmental disorder impairs channel gating.

Abstract
Ca2+ flux into axon terminals via P-/Q-type CaV2.1 channels is the trigger for neurotransmitter vesicle release at neuromuscular junctions (NMJs) and many central synapses. Recently, an arginine to proline substitution (R1673P) in the S4 voltage-sensing helix of the fourth membrane-bound repeat of CaV2.1 was linked to a severe neurological disorder characterized by generalized hypotonia, ataxia, cerebellar atrophy, and global developmental delay. The R1673P mutation was proposed to cause a gain of function in CaV2.1 leading to neuronal Ca2+ toxicity based on the ability of the mutant channel to rescue the photoreceptor response in CaV2.1-deficient Drosophila cacophony larvae. Here, we show that the corresponding mutation in rat CaV2.1 (R1624P) causes a profound loss of channel function; voltage-clamp analysis of tsA-201 cells expressing this mutant channel revealed an ∼25-mV depolarizing shift in the voltage dependence of activation. This alteration in activation implies that a significant fraction of CaV2.1 channels resident in presynaptic terminals are unlikely to open in response to an action potential, thereby increasing the probability of synaptic failure at both NMJs and central synapses. Indeed, the mutant channel supported only minimal Ca2+ flux in response to an action potential-like waveform. Application of GV-58, a compound previously shown to stabilize the open state of wild-type CaV2.1 channels, partially restored Ca2+ current by shifting mutant activation to more hyperpolarizing potentials and slowing deactivation. Consequently, GV-58 also rescued a portion of Ca2+ flux during action potential-like stimuli. Thus, our data raise the possibility that therapeutic agents that increase channel open probability or prolong action potential duration may be effective in combatting this and other severe neurodevelopmental disorders caused by loss-of-function mutations in CaV2.1.
AuthorsSidharth Tyagi, Tyler R Bendrick, Dilyana Filipova, Symeon Papadopoulos, Roger A Bannister
JournalThe Journal of general physiology (J Gen Physiol) Vol. 151 Issue 6 Pg. 850-859 (06 03 2019) ISSN: 1540-7748 [Electronic] United States
PMID31015257 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2019 Tyagi et al.
Chemical References
  • Calcium Channels, N-Type
  • voltage-dependent calcium channel (P-Q type)
  • Calcium
Topics
  • Action Potentials (genetics, physiology)
  • Animals
  • Calcium (metabolism)
  • Calcium Channels, N-Type (genetics)
  • Ion Channel Gating (genetics, physiology)
  • Mutation (genetics, physiology)
  • Neurodevelopmental Disorders (genetics, physiopathology)
  • Neuromuscular Junction (genetics, physiopathology)
  • Neurons (physiology)
  • Patch-Clamp Techniques (methods)
  • Presynaptic Terminals (physiology)
  • Rabbits
  • Rats
  • Synapses (genetics)
  • Synaptic Transmission (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: